PFIZER INC Interest Expense
PFIZER INC (PFE) reported Interest Expense of $667.00 million for the 3-month period ending 2026-06-28, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement
us-gaap:InterestExpense · last filed 2026-08-04
- PFIZER INC interest expense for the quarter ending 2026-06-28 was $667.00M, a 1.99% increase year-over-year.
- PFIZER INC interest expense for the quarter ending 2026-03-29 was $668.00M, a 2.14% increase year-over-year.
- PFIZER INC interest expense for the quarter ending 2025-12-31 was $711.00M, a 3.79% decline year-over-year.
- PFIZER INC interest expense for the quarter ending 2025-09-28 was $652.00M, a 16.73% decline year-over-year.
- PFIZER INC interest expense for fiscal 2025 was $2.67B, a 13.59% decline from fiscal 2024.
- PFIZER INC interest expense for fiscal 2024 was $3.09B, a 39.93% increase from fiscal 2023.
- PFIZER INC interest expense for fiscal 2023 was $2.21B, a 78.43% increase from fiscal 2022.
- PFIZER INC interest expense for fiscal 2022 was $1.24B, a 4.11% decline from fiscal 2021.
| Period end | Interest Expense 3 month | Interest Expense 3 month as first filed | Interest Expense 6 month | Interest Expense 6 month as first filed | Interest Expense 9 month | Interest Expense 9 month as first filed | Interest Expense 12 month | Interest Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-28 | $667.00M 10-Q · filed 2026-08-04 | $1.34B 10-Q · filed 2026-08-04 | $2.05B derived: sum of 3 quarters · filed 2026-08-04 | $2.70B derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2026-03-29 | $668.00M 10-Q · filed 2026-05-05 | $1.38B derived: sum of 2 quarters · filed 2026-05-05 | $2.03B derived: sum of 3 quarters · filed 2026-05-05 | $2.69B derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-12-31 | $711.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.36B derived: sum of 2 quarters · filed 2026-02-26 | $2.02B derived: sum of 3 quarters · filed 2026-08-04 | $2.67B 10-K · filed 2026-02-26 | ||||
| 2025-09-28 | $652.00M 10-Q · filed 2025-11-04 | $1.31B derived: sum of 2 quarters · filed 2026-08-04 | $1.96B 10-Q · filed 2025-11-04 | $2.70B derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-06-29 | $654.00M 10-Q · filed 2026-08-04 | $1.31B 10-Q · filed 2026-08-04 | $2.05B derived: sum of 3 quarters · filed 2026-08-04 | $2.83B derived: sum of 4 quarters · filed 2026-08-04 | ||||
| 2025-03-30 | $654.00M 10-Q · filed 2026-05-05 | $1.39B derived: sum of 2 quarters · filed 2026-05-05 | $2.18B derived: sum of 3 quarters · filed 2026-05-05 | $2.95B derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | $739.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.52B derived: sum of 2 quarters · filed 2026-02-26 | $2.30B derived: sum of 3 quarters · filed 2026-02-26 | $3.09B 10-K · filed 2026-02-26 | ||||
| 2024-09-29 | $783.00M 10-Q · filed 2025-11-04 | $1.56B derived: sum of 2 quarters · filed 2025-11-04 | $2.35B 10-Q · filed 2025-11-04 | $3.04B derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-06-30 | $778.00M 10-Q · filed 2025-08-05 | $1.57B 10-Q · filed 2025-08-05 | $2.26B derived: sum of 3 quarters · filed 2026-02-26 | $2.95B derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-03-31 | $790.00M 10-Q · filed 2025-05-05 | $1.48B derived: sum of 2 quarters · filed 2026-02-26 | $2.17B derived: sum of 3 quarters · filed 2026-02-26 | $2.68B derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2023-12-31 | $688.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.38B derived: sum of 2 quarters · filed 2026-02-26 | $1.89B derived: sum of 3 quarters · filed 2026-02-26 | $2.21B 10-K · filed 2026-02-26 | ||||
| 2023-10-01 | $695.00M 10-Q · filed 2024-11-04 | $1.20B derived: sum of 2 quarters · filed 2024-11-04 | $1.52B 10-Q · filed 2024-11-04 | $1.83B derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2023-07-02 | $508.00M 10-Q · filed 2024-08-05 | $826.00M 10-Q · filed 2024-08-05 | $1.14B derived: sum of 3 quarters · filed 2025-02-27 | $1.45B derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2023-04-02 | $318.00M 10-Q · filed 2024-05-08 | $631.00M derived: sum of 2 quarters · filed 2025-02-27 | $942.00M derived: sum of 3 quarters · filed 2025-02-27 | $1.24B derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2022-12-31 | $313.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $624.00M derived: sum of 2 quarters · filed 2025-02-27 | $917.00M derived: sum of 3 quarters · filed 2025-02-27 | $1.24B 10-K · filed 2025-02-27 | ||||
| 2022-10-02 | $311.00M 10-Q · filed 2023-11-08 | $604.00M derived: sum of 2 quarters · filed 2023-11-08 | $925.00M 10-Q · filed 2023-11-08 | $1.24B derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2022-07-03 | $293.00M 10-Q · filed 2023-08-09 | $614.00M 10-Q · filed 2023-08-09 | $931.00M derived: sum of 3 quarters · filed 2024-02-22 | $1.26B derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2022-04-03 | $322.00M 10-Q · filed 2023-05-10 | $638.00M derived: sum of 2 quarters · filed 2024-02-22 | $963.00M derived: sum of 3 quarters · filed 2024-02-22 | $1.28B derived: sum of 4 quarters · filed 2024-02-22 | ||||
| 2021-12-31 | $316.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $641.00M derived: sum of 2 quarters · filed 2024-02-22 | $957.00M derived: sum of 3 quarters · filed 2024-02-22 | $1.29B 10-K · filed 2024-02-22 | ||||
| 2021-10-03 | $325.00M 10-Q · filed 2022-11-09 | $641.00M derived: sum of 2 quarters · filed 2022-11-09 | $975.00M 10-Q · filed 2022-11-09 | $1.32B derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2021-07-04 | $316.00M 10-Q · filed 2022-08-10 | $651.00M 10-Q · filed 2022-08-10 | $999.00M derived: sum of 3 quarters · filed 2023-02-23 | $1.34B derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2021-04-04 | $336.00M 10-Q · filed 2022-05-11 | $683.00M derived: sum of 2 quarters · filed 2023-02-23 | $1.03B derived: sum of 3 quarters · filed 2023-02-23 | $1.40B derived: sum of 4 quarters · filed 2023-02-23 | ||||
| 2020-12-31 | $347.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $692.00M derived: sum of 2 quarters · filed 2023-02-23 | $1.06B derived: sum of 3 quarters · filed 2023-02-23 | $1.45B 10-K · filed 2023-02-23 | ||||
| 2020-09-27 | $345.00M 10-Q · filed 2021-11-12 | $416.00M 10-Q · filed 2020-11-05 | $712.00M derived: sum of 2 quarters · filed 2021-11-12 | $1.10B 10-Q · filed 2021-11-12 | $1.18B 10-Q · filed 2020-11-05 | $1.52B derived: sum of 4 quarters · filed 2022-02-24 | ||
| 2020-06-28 | $367.00M 10-Q · filed 2021-08-12 | $372.00M 10-Q · filed 2020-08-06 | $757.00M 10-Q · filed 2021-08-12 | $762.00M 10-Q · filed 2020-08-06 | $1.17B derived: sum of 3 quarters · filed 2022-02-24 | $1.58B derived: sum of 4 quarters · filed 2022-02-24 | ||
| 2020-03-29 | $390.00M 10-Q · filed 2021-05-13 | $805.00M derived: sum of 2 quarters · filed 2022-02-24 | $1.21B derived: sum of 3 quarters · filed 2022-02-24 | $1.60B derived: sum of 4 quarters · filed 2022-02-24 | ||||
| 2019-12-31 | $415.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $824.00M derived: sum of 2 quarters · filed 2022-02-24 | $1.21B derived: sum of 3 quarters · filed 2022-02-24 | $1.57B 10-K · filed 2022-02-24 | $1.57B 10-K · filed 2020-02-27 | |||
| 2019-09-29 | $409.00M 10-Q · filed 2020-11-05 | $798.00M derived: sum of 2 quarters · filed 2020-11-05 | $1.16B 10-Q · filed 2020-11-05 | $1.53B derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-06-30 | $389.00M 10-Q · filed 2020-08-06 | $750.00M 10-Q · filed 2020-08-06 | $1.12B derived: sum of 3 quarters · filed 2021-02-25 | $1.43B derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-03-31 | $361.00M 10-Q · filed 2020-05-07 | $731.00M derived: sum of 2 quarters · filed 2021-02-25 | $1.04B derived: sum of 3 quarters · filed 2021-02-25 | $1.37B derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2018-12-31 | $370.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $680.00M derived: sum of 2 quarters · filed 2021-02-25 | $1.01B derived: sum of 3 quarters · filed 2021-02-25 | $1.32B 10-K · filed 2021-02-25 | ||||
| 2018-09-30 | $310.00M 10-Q · filed 2019-11-07 | $636.00M derived: sum of 2 quarters · filed 2019-11-07 | $946.00M 10-Q · filed 2019-11-07 | $1.28B derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-07-01 | $326.00M 10-Q · filed 2019-08-08 | $635.00M 10-Q · filed 2019-08-08 | $966.00M derived: sum of 3 quarters · filed 2020-02-27 | $1.29B derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2018-04-01 | $310.00M 10-Q · filed 2019-05-09 | $640.00M derived: sum of 2 quarters · filed 2020-02-27 | $960.00M derived: sum of 3 quarters · filed 2020-02-27 | $1.27B derived: sum of 4 quarters · filed 2020-02-27 | ||||
| 2017-12-31 | $330.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $650.00M derived: sum of 2 quarters · filed 2020-02-27 | $962.00M derived: sum of 3 quarters · filed 2020-02-27 | $1.27B 10-K · filed 2020-02-27 | ||||
| 2017-10-01 | $320.00M 10-Q · filed 2018-11-08 | $632.00M derived: sum of 2 quarters · filed 2018-11-08 | $940.00M 10-Q · filed 2018-11-08 | $1.24B derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2017-07-02 | $312.00M 10-Q · filed 2018-08-09 | $621.00M 10-Q · filed 2018-08-09 | $918.00M derived: sum of 3 quarters · filed 2019-02-28 | $1.21B derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2017-04-02 | $309.00M 10-Q · filed 2018-05-10 | $606.00M derived: sum of 2 quarters · filed 2019-02-28 | $897.00M derived: sum of 3 quarters · filed 2019-02-28 | $1.19B derived: sum of 4 quarters · filed 2019-02-28 | ||||
| 2016-12-31 | $297.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $588.00M derived: sum of 2 quarters · filed 2019-02-28 | $880.00M derived: sum of 3 quarters · filed 2019-02-28 | $1.19B 10-K · filed 2019-02-28 | ||||
| 2016-10-02 | $291.00M 10-Q · filed 2017-11-09 | $583.00M derived: sum of 2 quarters · filed 2017-11-09 | $889.00M 10-Q · filed 2017-11-09 | $1.22B derived: sum of 4 quarters · filed 2018-02-22 | ||||
| 2016-07-03 | $292.00M 10-Q · filed 2017-08-10 | $598.00M 10-Q · filed 2017-08-10 | $933.00M derived: sum of 3 quarters · filed 2018-02-22 | $1.21B derived: sum of 4 quarters · filed 2018-02-22 | ||||
| 2016-04-03 | $306.00M 10-Q · filed 2017-05-11 | $641.00M derived: sum of 2 quarters · filed 2018-02-22 | $919.00M derived: sum of 3 quarters · filed 2018-02-22 | $1.20B derived: sum of 4 quarters · filed 2018-02-22 | ||||
| 2015-12-31 | $335.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | $613.00M derived: sum of 2 quarters · filed 2018-02-22 | $891.00M derived: sum of 3 quarters · filed 2018-02-22 | $1.20B 10-K · filed 2018-02-22 | ||||
| 2015-09-27 | $278.00M 10-Q · filed 2016-11-10 | $556.00M derived: sum of 2 quarters · filed 2016-11-10 | $864.00M 10-Q · filed 2016-11-10 | $1.22B derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2015-06-28 | $278.00M 10-Q · filed 2016-08-11 | $587.00M 10-Q · filed 2016-08-11 | $940.00M derived: sum of 3 quarters · filed 2017-02-23 | $1.28B derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2015-03-29 | $309.00M 10-Q · filed 2016-05-12 | $662.00M derived: sum of 2 quarters · filed 2017-02-23 | $1.00B derived: sum of 3 quarters · filed 2017-02-23 | $1.35B derived: sum of 4 quarters · filed 2017-02-23 | ||||
| 2014-12-31 | $353.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $696.00M derived: sum of 2 quarters · filed 2017-02-23 | $1.04B derived: sum of 3 quarters · filed 2017-02-23 | $1.36B 10-K · filed 2017-02-23 | ||||
| 2014-09-28 | $343.00M 10-Q · filed 2015-11-05 | $686.00M derived: sum of 2 quarters · filed 2015-11-05 | $1.01B 10-Q · filed 2015-11-05 | $1.35B derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-06-29 | $343.00M 10-Q · filed 2015-08-06 | $664.00M 10-Q · filed 2015-08-06 | $1.01B derived: sum of 3 quarters · filed 2016-02-29 | $1.35B derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-03-30 | $321.00M 10-Q · filed 2015-05-07 | $668.00M derived: sum of 2 quarters · filed 2016-02-29 | $1.01B derived: sum of 3 quarters · filed 2016-02-29 | $1.36B derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2013-12-31 | $347.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $687.00M derived: sum of 2 quarters · filed 2016-02-29 | $1.04B derived: sum of 3 quarters · filed 2016-02-29 | $1.41B 10-K · filed 2016-02-29 | ||||
| 2013-09-29 | $340.00M 10-Q · filed 2014-11-06 | $696.00M derived: sum of 2 quarters · filed 2014-11-06 | $1.07B 10-Q · filed 2014-11-06 | $1.44B derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2013-06-30 | $356.00M 10-Q · filed 2014-08-07 | $727.00M 10-Q · filed 2014-08-07 | $1.10B derived: sum of 3 quarters · filed 2015-02-27 | $1.48B derived: sum of 4 quarters · filed 2015-02-27 | ||||
| 2013-03-31 | $371.00M 10-Q · filed 2014-05-08 | $391.00M 10-Q · filed 2013-05-10 | $744.00M derived: sum of 2 quarters · filed 2015-02-27 | $1.13B derived: sum of 3 quarters · filed 2015-02-27 | $1.50B derived: sum of 4 quarters · filed 2015-02-27 | |||
| 2012-12-31 | $373.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | $754.00M derived: sum of 2 quarters · filed 2015-02-27 | $1.13B derived: sum of 3 quarters · filed 2015-02-27 | $1.52B 10-K · filed 2015-02-27 | $1.52B 10-K · filed 2013-02-28 | |||
| 2012-09-30 | $381.00M 10-Q · filed 2013-11-08 | $382.00M 10-Q · filed 2012-11-09 | $759.00M derived: sum of 2 quarters · filed 2013-11-08 | $1.15B 10-Q · filed 2013-11-08 | $1.15B 10-Q · filed 2012-11-09 | $1.54B derived: sum of 4 quarters · filed 2014-02-28 | ||
| 2012-07-01 | $378.00M 10-Q · filed 2013-08-09 | $379.00M 10-Q · filed 2012-08-09 | $768.00M 10-Q · filed 2013-08-09 | $769.00M 10-Q · filed 2012-08-09 | $1.16B derived: sum of 3 quarters · filed 2014-02-28 | $1.59B derived: sum of 4 quarters · filed 2014-02-28 | ||
| 2012-04-01 | $390.00M 10-Q · filed 2013-05-10 | $786.00M derived: sum of 2 quarters · filed 2014-02-28 | $1.21B derived: sum of 3 quarters · filed 2014-02-28 | $1.61B derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2011-12-31 | $396.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | $819.00M derived: sum of 2 quarters · filed 2014-02-28 | $1.22B derived: sum of 3 quarters · filed 2014-02-28 | $1.68B 10-K · filed 2014-02-28 | ||||
| 2011-10-02 | $423.00M 10-Q · filed 2012-11-09 | $827.00M derived: sum of 2 quarters · filed 2012-11-09 | $1.28B 10-Q · filed 2012-11-09 | $1.74B derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-07-03 | $404.00M 10-Q · filed 2011-08-11 | $862.00M 10-Q · filed 2012-08-09 | $1.32B derived: sum of 3 quarters · filed 2013-02-28 | $1.75B derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2011-04-03 | $458.00M 10-Q · filed 2012-05-10 | $916.00M derived: sum of 2 quarters · filed 2013-02-28 | $1.34B derived: sum of 3 quarters · filed 2013-02-28 | $1.73B derived: sum of 4 quarters · filed 2013-02-28 | ||||
| 2010-12-31 | $458.00M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $885.00M derived: sum of 2 quarters · filed 2013-02-28 | $1.27B derived: sum of 3 quarters · filed 2013-02-28 | $1.80B 10-K · filed 2013-02-28 | $1.80B 10-K · filed 2011-02-28 | |||
| 2010-10-03 | $427.00M 10-Q · filed 2011-11-10 | $428.00M 10-Q · filed 2010-11-12 | $816.00M derived: sum of 2 quarters · filed 2011-11-10 | $1.34B 10-Q · filed 2011-11-10 | $1.80B derived: sum of 4 quarters · filed 2012-02-28 | |||
| 2010-07-04 | $389.00M 10-Q · filed 2011-08-11 | $911.00M 10-Q · filed 2011-08-11 | $1.37B derived: sum of 3 quarters · filed 2012-02-28 | $1.74B derived: sum of 4 quarters · filed 2012-02-28 | ||||
| 2010-04-04 | $522.00M 10-Q · filed 2011-05-12 | $985.00M derived: sum of 2 quarters · filed 2012-02-28 | $1.35B derived: sum of 3 quarters · filed 2012-02-28 | |||||
| 2009-12-31 | $463.00M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | $832.00M derived: sum of 2 quarters · filed 2012-02-28 | $1.23B 10-K · filed 2012-02-28 | $1.23B 10-K · filed 2011-02-28 | ||||
| 2009-09-27 | $369.00M 10-Q · filed 2010-11-12 | $769.00M 10-Q · filed 2010-11-12 | ||||||
| 2008-12-31 | $516.00M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |